Do you think India will be swept up in the $100Bn global surge of anti-obesity drugs? Join us at #ScaleUpHealth2024 as we hear this expert panel discuss this very question and share their views. We have limited seats, so if you haven’t already registered your interest to attend,

Congratulations to Adaptimmune on the U.S. FDA approval of TECELRA®. TECELRA is the first engineered #celltherapy for a solid tumor #cancer approved in the U.S., and the first new therapy option in over a decade for synovial sarcoma. Learn more: bwnews.pr/4fwjt6A

Congratulations to Shinobi Therapeutics on being awarded grant funding from the Japanese AMED. This grant will support Shinobi Therapeutics’ lead program working to develop an iPS-T #celltherapy targeting GPC3+ solid tumor #cancers. Learn more: bit.ly/3AdYzZB

Excited to share our look back on fintech’s first 6-month of 2024. TLDR: Q2 Fintech multiples decrease from 4.8x to 4.4x. LTM revenue growth across the sector slowed down due to lack of #Fintech exits + broad macro factors..& Neobanking can be profitable fintechprimetime.substack.com/p/are-neobanks…

Huge congratulations to Benchling and Plaid for landing on Forbes annual #Cloud100 list of the top private cloud computing companies! Also shout out to our sister Eight Roads Ventures and their high-flying cloud companies: @HiBob_HR, Icertis, AppsFlyer! forbes.com/lists/cloud100/

Congratulations to NodThera on your recognition as a 2024 FierceBiotech #Fierce15 company. Nodthera was highlighted for their unique approach to inflammatory-driven diseases by targeting the NLRP3 inflammasome. Learn more: bit.ly/3WRKJ85 #biotech #healthcare

Congrats to our portfolio companies 1upHealth, AvantStay, Capital Rx, ConnexPay, embarkvet, and Vestwell for making the 2024 #Inc5000 list. This annual list recognizes the fastest-growing private US companies based on their revenue growth. Learn more: bit.ly/4dIvRhR

Congrats to AviadoBio and Neumora for being named in Labiotech.eu‘s “10 #neuroscience biotech companies you should know about” list! This list features promising #biotech companies working to advance treatments for neurological diseases. Learn more: bit.ly/3Z3mMfK

#Science2Startup 2024 united academics, entrepreneurs, industry leaders & VCs for a dynamic exchange of ideas. The symposium showcased exceptional scientists from global research institutions, all working on pioneering advancements in science. Learn more: science2startup.com

Introducing "Pioneering Progress," a series sharing stories of innovative drugs/products and F-Prime's role in advancing #science and #patientcare. The first article features FARAPULSE, a revolutionary PFA system for #AtrialFibrillation treatment: bit.ly/3XDh3fp

Congratulations to Insilico Medicine and Rallybio for being named Innovation Honorees in FiercePharma's 2024 Fierce 50. Learn more: ▪️ Insilico Medicine - bit.ly/3BcbHyJ ▪️ Rallybio - bit.ly/4gpWJWg #pharma #healthcare #drugdevelopment

Congratulations to Centivo on securing your latest round of financing. This capital will accelerate their mission of delivering high-quality, affordable #healthcare to working families. Learn more: bit.ly/3ZCqAon

Congratulations to XairaTherapeutics and Metsera for being recognized as winners in this year's Endpoints 11. The Endpoints News list highlights #biotech #startups leveraging AI to transform drug R&D and tackle major diseases, rare conditions, and more. Learn more: bit.ly/4eIaqOK

This summer, F-Prime Capital was excited to welcome a talented group of interns and fellows to our Cambridge office. Discover what it's like to be part of our #internship and #fellowship programs: bit.ly/4eiXEpU